Back

SYNTAX score and outcomes after coronary artery bypass grafting: a long-term follow-up analysis

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Risk scores at coronary revascularisation Coronary Arteries ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Eduardo Martins

University of Sao Paulo, Sao Paulo (Brazil)

9 More presentations in this session

Presentation thumbnail
Syntax-Score II Based Assessment for role of complete revascularization by using percutaneous coronary intervention among Patients with Chronic Total Occlusion
Doctor M. Shiba (Tokyo, JP)
Abstract
Presentation thumbnail
Enhanced bedside PCI risk score predicting major adverse cardiovascular events
Doctor L. Wang (Singapore, SG)
Abstract Slides
Presentation thumbnail
Validation of an NCDR-score-based risk model for cardiac catheterization procedures in a european population
Doctor M. Brockmeyer (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
The ARDVAARC study: real-world outcomes and the utility of bleeding risk scores in patients who require anticoagulation following percutaneous coronary intervention (PCI)
Doctor M. Li Kam Wa (London, GB)
Abstract Slides
Presentation thumbnail
Utility of SYNTAX score II in revascularization decision-making process in patients with acute coronary syndrome without local heart surgery facilities
Doctor F. Abcha (Tunis, TN)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 7 - Risk scores at coronary revascularisation

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Anomalous left main coronary artery arising from the right coronary sinus presenting with ST elevation and non ST elevation myocardial infarction
thumbnail
Congress Presentation
Surgical correction of anomalous origin of the coronary artery: a scoping review on clinical outcomes, techniques, and knowledge gaps
thumbnail
Webinar
Chronic coronary syndrome post-myocardial infarction: disease progression and comorbidities

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources